Inhibition of EphA2/EphrinA1 signal attenuates lipopolysaccharide-induced lung injury

Ji Young Hong, Mi Hwa Shin, Ivor S. Douglas, Kyung Soo Chung, Eun Young Kim, Ji Ye Jung, youngae kang, Se Kyu Kim, Joon Chang, Young Sam Kim, Moo Suk Park

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Eph-Ephrin signalling mediates various cellular processes, including vasculogenesis, angiogenesis, cell migration, axon guidance, fluid homoeostasis and repair after injury. Although previous studies have demonstrated that stimulation of the EphA receptor induces increased vascular permeability and inflammatory response in lung injury, the detailed mechanisms of EphA2 signalling are unknown. In the present study, we evaluated the role of EphA2 signalling in mice with lipopolysaccharide (LPS)-induced lung injury. Acute LPS exposure significantly up-regulated EphA2 and EphrinA1 expression. Compared with LPS + IgG mice (IgG instillation after LPS exposure), LPS + EphA2 mAb mice [EphA2 monoclonal antibody (mAb) instillation posttreatment after LPS exposure] had attenuated lung injury and reduced cell counts and protein concentration of bronchoalveolar lavage fluid (BALF). EphA2 mAb posttreatment down-regulated the expression of phosphoinositide 3-kinases (PI3K) 110γ, phospho-Akt, phospho-NF-κB p65, phospho-Src and phospho-S6K in lung lysates. In addition, inhibiting the EphA2 receptor augmented the expression of E-cadherin, which is involved in cell-cell adhesion. Our study identified EphA2 receptor as an unrecognized modulator of several signalling pathways - including PI3K-Akt-NF-kB, Src-NF-κB, E-cadherin and mTOR - in LPS-induced lung injury. These results suggest that EphA2 receptor inhibitors may function as novel therapeutic agents for LPS-induced lung injury.

Original languageEnglish
Pages (from-to)1993-2003
Number of pages11
JournalClinical Science
Volume130
Issue number21
DOIs
Publication statusPublished - 2016 Jan 1

Fingerprint

Lung Injury
Lipopolysaccharides
EphA2 Receptor
1-Phosphatidylinositol 4-Kinase
Monoclonal Antibodies
Cadherins
Immunoglobulin G
Eph Family Receptors
Ephrins
NF-kappa B
Bronchoalveolar Lavage Fluid
Capillary Permeability
Cell Adhesion
Cell Movement
Homeostasis
Cell Count
Lung
Wounds and Injuries

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Hong, J. Y., Shin, M. H., Douglas, I. S., Chung, K. S., Kim, E. Y., Jung, J. Y., ... Park, M. S. (2016). Inhibition of EphA2/EphrinA1 signal attenuates lipopolysaccharide-induced lung injury. Clinical Science, 130(21), 1993-2003. https://doi.org/10.1042/CS20160360
Hong, Ji Young ; Shin, Mi Hwa ; Douglas, Ivor S. ; Chung, Kyung Soo ; Kim, Eun Young ; Jung, Ji Ye ; kang, youngae ; Kim, Se Kyu ; Chang, Joon ; Kim, Young Sam ; Park, Moo Suk. / Inhibition of EphA2/EphrinA1 signal attenuates lipopolysaccharide-induced lung injury. In: Clinical Science. 2016 ; Vol. 130, No. 21. pp. 1993-2003.
@article{f2382aabddca476eafb501d850f48c4d,
title = "Inhibition of EphA2/EphrinA1 signal attenuates lipopolysaccharide-induced lung injury",
abstract = "Eph-Ephrin signalling mediates various cellular processes, including vasculogenesis, angiogenesis, cell migration, axon guidance, fluid homoeostasis and repair after injury. Although previous studies have demonstrated that stimulation of the EphA receptor induces increased vascular permeability and inflammatory response in lung injury, the detailed mechanisms of EphA2 signalling are unknown. In the present study, we evaluated the role of EphA2 signalling in mice with lipopolysaccharide (LPS)-induced lung injury. Acute LPS exposure significantly up-regulated EphA2 and EphrinA1 expression. Compared with LPS + IgG mice (IgG instillation after LPS exposure), LPS + EphA2 mAb mice [EphA2 monoclonal antibody (mAb) instillation posttreatment after LPS exposure] had attenuated lung injury and reduced cell counts and protein concentration of bronchoalveolar lavage fluid (BALF). EphA2 mAb posttreatment down-regulated the expression of phosphoinositide 3-kinases (PI3K) 110γ, phospho-Akt, phospho-NF-κB p65, phospho-Src and phospho-S6K in lung lysates. In addition, inhibiting the EphA2 receptor augmented the expression of E-cadherin, which is involved in cell-cell adhesion. Our study identified EphA2 receptor as an unrecognized modulator of several signalling pathways - including PI3K-Akt-NF-kB, Src-NF-κB, E-cadherin and mTOR - in LPS-induced lung injury. These results suggest that EphA2 receptor inhibitors may function as novel therapeutic agents for LPS-induced lung injury.",
author = "Hong, {Ji Young} and Shin, {Mi Hwa} and Douglas, {Ivor S.} and Chung, {Kyung Soo} and Kim, {Eun Young} and Jung, {Ji Ye} and youngae kang and Kim, {Se Kyu} and Joon Chang and Kim, {Young Sam} and Park, {Moo Suk}",
year = "2016",
month = "1",
day = "1",
doi = "10.1042/CS20160360",
language = "English",
volume = "130",
pages = "1993--2003",
journal = "Clinical Science",
issn = "0143-5221",
publisher = "Portland Press Ltd.",
number = "21",

}

Hong, JY, Shin, MH, Douglas, IS, Chung, KS, Kim, EY, Jung, JY, kang, Y, Kim, SK, Chang, J, Kim, YS & Park, MS 2016, 'Inhibition of EphA2/EphrinA1 signal attenuates lipopolysaccharide-induced lung injury', Clinical Science, vol. 130, no. 21, pp. 1993-2003. https://doi.org/10.1042/CS20160360

Inhibition of EphA2/EphrinA1 signal attenuates lipopolysaccharide-induced lung injury. / Hong, Ji Young; Shin, Mi Hwa; Douglas, Ivor S.; Chung, Kyung Soo; Kim, Eun Young; Jung, Ji Ye; kang, youngae; Kim, Se Kyu; Chang, Joon; Kim, Young Sam; Park, Moo Suk.

In: Clinical Science, Vol. 130, No. 21, 01.01.2016, p. 1993-2003.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Inhibition of EphA2/EphrinA1 signal attenuates lipopolysaccharide-induced lung injury

AU - Hong, Ji Young

AU - Shin, Mi Hwa

AU - Douglas, Ivor S.

AU - Chung, Kyung Soo

AU - Kim, Eun Young

AU - Jung, Ji Ye

AU - kang, youngae

AU - Kim, Se Kyu

AU - Chang, Joon

AU - Kim, Young Sam

AU - Park, Moo Suk

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Eph-Ephrin signalling mediates various cellular processes, including vasculogenesis, angiogenesis, cell migration, axon guidance, fluid homoeostasis and repair after injury. Although previous studies have demonstrated that stimulation of the EphA receptor induces increased vascular permeability and inflammatory response in lung injury, the detailed mechanisms of EphA2 signalling are unknown. In the present study, we evaluated the role of EphA2 signalling in mice with lipopolysaccharide (LPS)-induced lung injury. Acute LPS exposure significantly up-regulated EphA2 and EphrinA1 expression. Compared with LPS + IgG mice (IgG instillation after LPS exposure), LPS + EphA2 mAb mice [EphA2 monoclonal antibody (mAb) instillation posttreatment after LPS exposure] had attenuated lung injury and reduced cell counts and protein concentration of bronchoalveolar lavage fluid (BALF). EphA2 mAb posttreatment down-regulated the expression of phosphoinositide 3-kinases (PI3K) 110γ, phospho-Akt, phospho-NF-κB p65, phospho-Src and phospho-S6K in lung lysates. In addition, inhibiting the EphA2 receptor augmented the expression of E-cadherin, which is involved in cell-cell adhesion. Our study identified EphA2 receptor as an unrecognized modulator of several signalling pathways - including PI3K-Akt-NF-kB, Src-NF-κB, E-cadherin and mTOR - in LPS-induced lung injury. These results suggest that EphA2 receptor inhibitors may function as novel therapeutic agents for LPS-induced lung injury.

AB - Eph-Ephrin signalling mediates various cellular processes, including vasculogenesis, angiogenesis, cell migration, axon guidance, fluid homoeostasis and repair after injury. Although previous studies have demonstrated that stimulation of the EphA receptor induces increased vascular permeability and inflammatory response in lung injury, the detailed mechanisms of EphA2 signalling are unknown. In the present study, we evaluated the role of EphA2 signalling in mice with lipopolysaccharide (LPS)-induced lung injury. Acute LPS exposure significantly up-regulated EphA2 and EphrinA1 expression. Compared with LPS + IgG mice (IgG instillation after LPS exposure), LPS + EphA2 mAb mice [EphA2 monoclonal antibody (mAb) instillation posttreatment after LPS exposure] had attenuated lung injury and reduced cell counts and protein concentration of bronchoalveolar lavage fluid (BALF). EphA2 mAb posttreatment down-regulated the expression of phosphoinositide 3-kinases (PI3K) 110γ, phospho-Akt, phospho-NF-κB p65, phospho-Src and phospho-S6K in lung lysates. In addition, inhibiting the EphA2 receptor augmented the expression of E-cadherin, which is involved in cell-cell adhesion. Our study identified EphA2 receptor as an unrecognized modulator of several signalling pathways - including PI3K-Akt-NF-kB, Src-NF-κB, E-cadherin and mTOR - in LPS-induced lung injury. These results suggest that EphA2 receptor inhibitors may function as novel therapeutic agents for LPS-induced lung injury.

UR - http://www.scopus.com/inward/record.url?scp=84991586386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991586386&partnerID=8YFLogxK

U2 - 10.1042/CS20160360

DO - 10.1042/CS20160360

M3 - Article

VL - 130

SP - 1993

EP - 2003

JO - Clinical Science

JF - Clinical Science

SN - 0143-5221

IS - 21

ER -

Hong JY, Shin MH, Douglas IS, Chung KS, Kim EY, Jung JY et al. Inhibition of EphA2/EphrinA1 signal attenuates lipopolysaccharide-induced lung injury. Clinical Science. 2016 Jan 1;130(21):1993-2003. https://doi.org/10.1042/CS20160360